The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients
2019 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients
Mader, M. M. Mader, Marius Marc-Daniel; Rotermund, R.; Martens, T.; Westphal, M.; Matschke, J. & Abboud, T. (2019)
Journal of Neuro-Oncology, 141(1) pp. 183-194. DOI: https://doi.org/10.1007/s11060-018-03024-8
Documents & Media
Details
- Authors
- Mader, Marius Marc-Daniel; Rotermund, Roman; Martens, Tobias; Westphal, Manfred; Matschke, Jakob; Abboud, Tammam
- Abstract
- With the 2016 World Health Organization Classification of Tumors of the Central Nervous System (2016 CNS WHO), diagnosis of glioma is based on molecular parameters in addition to histology potentially leading to additional demands on quality of tissue samples. This may challenge the role of minimally invasive biopsy procedures. This study aims to evaluate the diagnostic yield of glioma samples from frameless stereotactic biopsies with focus on molecular information and explore the neuromolecular profile of a glioma biopsy cohort.
- Issue Date
- 2019
- Journal
- Journal of Neuro-Oncology
- eISSN
- 1573-7373
- Language
- English
